Search research articles
Contact Us
Filters
Showing results (41-50 of 124) with videos related to
Page
of 13
Sort By:
European Journal of Human Genetics : EJHG
|
October 31, 2002
Detection of putative functional angiotensinogen (AGT) gene variants controlling plasma AGT levels by combined segregation-linkage analysis
Eva Brand, Nathalie Chatelain, Françoise Paillard, et al.
Molecular Genetics and Metabolism
|
May 26, 2016
Fabry in the older patient: Clinical consequences and possibilities for treatment
Olivier Lidove, Frédéric Barbey, Dau-Ming Niu, et al.
Frontiers in Cardiovascular Medicine
|
November 29, 2023
Impact of enzyme replacement therapy and migalastat on left atrial strain and cardiomyopathy in patients with Fabry disease
Christian Pogoda, Stefan-Martin Brand, Thomas Duning, et al.
Plos One
|
February 9, 2013
Multifocal white matter lesions associated with the D313Y mutation of the α-galactosidase A gene
Malte Lenders, Thomas Duning, Michael Schelleckes, et al.
Journal of Inherited Metabolic Disease
|
October 7, 2019
Neutralising anti-drug antibodies in Fabry disease can inhibit endothelial enzyme uptake and activity
Franciska Stappers, David Scharnetzki, Boris Schmitz, et al.
Biotechnology Journal
|
October 17, 2013
Mini-scale cultivation method enables expeditious plasmid production in Escherichia coli
Petra Grunzel, Maciej Pilarek, Dörte Steinbrück, et al.
International Journal of Molecular Sciences
|
November 13, 2021
α-Galactosidase a Deficiency in Fabry Disease Leads to Extensive Dysregulated Cellular Signaling Pathways in Human Podocytes
Ulrich Jehn, Samet Bayraktar, Solvey Pollmann, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
April 13, 2019
Effects of high-intensity interval training on microvascular glycocalyx and associated microRNAs
Boris Schmitz, Hannah Niehues, Malte Lenders, et al.
Plos One
|
September 30, 2020
CRISPR/Cas9-mediated correction of mutated copper transporter ATP7B
Michael Pöhler, Sarah Guttmann, Oksana Nadzemova, et al.
Orphanet Journal of Rare Diseases
|
February 20, 2025
Impact of enzyme replacement therapy and migalastat on disease progression in females with fabry disease
Malte Lenders, Albina Nowak, Markus Cybulla, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 124) with videos related to
Sort By:
Page
of 13
European Journal of Human Genetics : EJHG
|
October 31, 2002
Detection of putative functional angiotensinogen (AGT) gene variants controlling plasma AGT levels by combined segregation-linkage analysis
Eva Brand, Nathalie Chatelain, Françoise Paillard, et al.
Molecular Genetics and Metabolism
|
May 26, 2016
Fabry in the older patient: Clinical consequences and possibilities for treatment
Olivier Lidove, Frédéric Barbey, Dau-Ming Niu, et al.
Frontiers in Cardiovascular Medicine
|
November 29, 2023
Impact of enzyme replacement therapy and migalastat on left atrial strain and cardiomyopathy in patients with Fabry disease
Christian Pogoda, Stefan-Martin Brand, Thomas Duning, et al.
Plos One
|
February 9, 2013
Multifocal white matter lesions associated with the D313Y mutation of the α-galactosidase A gene
Malte Lenders, Thomas Duning, Michael Schelleckes, et al.
Journal of Inherited Metabolic Disease
|
October 7, 2019
Neutralising anti-drug antibodies in Fabry disease can inhibit endothelial enzyme uptake and activity
Franciska Stappers, David Scharnetzki, Boris Schmitz, et al.
Biotechnology Journal
|
October 17, 2013
Mini-scale cultivation method enables expeditious plasmid production in Escherichia coli
Petra Grunzel, Maciej Pilarek, Dörte Steinbrück, et al.
International Journal of Molecular Sciences
|
November 13, 2021
α-Galactosidase a Deficiency in Fabry Disease Leads to Extensive Dysregulated Cellular Signaling Pathways in Human Podocytes
Ulrich Jehn, Samet Bayraktar, Solvey Pollmann, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
April 13, 2019
Effects of high-intensity interval training on microvascular glycocalyx and associated microRNAs
Boris Schmitz, Hannah Niehues, Malte Lenders, et al.
Plos One
|
September 30, 2020
CRISPR/Cas9-mediated correction of mutated copper transporter ATP7B
Michael Pöhler, Sarah Guttmann, Oksana Nadzemova, et al.
Orphanet Journal of Rare Diseases
|
February 20, 2025
Impact of enzyme replacement therapy and migalastat on disease progression in females with fabry disease
Malte Lenders, Albina Nowak, Markus Cybulla, et al.
Page
of 13